Auregen BioTherapeutics
Cambridge, United States· Est. 2020
Auregen BioTherapeutics develops gene therapies for rare genetic diseases using novel delivery platforms.
Private Company
Funding information not available
About
Auregen BioTherapeutics develops gene therapies for rare genetic diseases using novel delivery platforms.
Tissue Engineering